Article
The beginning is the decisive battle, the beginning is the sprint
XellSmart is committed to providing large-scale, low-cost stem cell therapy solutions for a series of major diseases such as Parkinson's disease for which there is no clinical solution.
Under the leadership of Dr. Li Xiang, XellSmart has independently designed and constructed a 1,600 m2 R&D center and is building a 3,500 m2 production transformation base. Xellsmart has established key technology platforms, such as the reprogramming of iPS cell lines, the iPSC gene editing platform, and the transfer of iPSCs to different sub-type neuronal cells, animal model of Parkinson's disease for evaluation of the safety and efficacy of cell-based drugs, and issued relevant patents.
At present, XellSmart has completed successive rounds financing with total amount over 100 million RMB. The investors includes FreesFund (leading the angel round), Lilly Asia Ventures, Qiming Ventures (co-leading the PreA round), Sequoia China (leading the PreA+ round), YuanBio Venture Capital, TEDA Venture Capital, Tao Capital, NEXT Capital, and Leader Venture Capital.
The beginning is the decisive battle, the beginning is the sprint
Founder, Chairman, CEO and CSO of Shize Biopharmaceutical Co., Ltd
Ph.D. in Life Sciences, Peking University
Postdoc at the University of Wisconsin-Madison
Vice Chairman of the Eighth Council of Jiangsu Biotechnology Association
Senior Engineer of Biomedical Engineering, Suzhou City, Jiangsu Province
Suzhou Industrial Park Technology Leading Talent
2021 Golden Award 30 Outstanding Young Innovators in China
Former Senior Scientist of Sana Biotechnology (NASDAQ: SANA)
FREES We firmly believe that being
right is more important than being
easy
Enlighten the public with wisdom
and learn with diligence。
We fight disease, save lives and
improve human health Provide
industry experience, global
resources and long-term capital.
Sequoia China, the entrepreneur
behind the entrepreneur, is
committed to discovering and
cultivating [towering trees] in the
industry.
TEDA Tech We believe that
technology creates value.
professional focus, steady and
pragmatic.
Innovator's first money
Discover the Next Big Thing.
Focus on medical and health
investment to promote the
development of life sciences.